Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1391 ARTÍCULOS , VIENDO DEL 1 AL 15

Divergent processing of monetary and social reward in behavioral variant frontotemporal dementia and Alzheimer disease

Perry DC, Sturm VE, Wood KA, Miller BL, Kramer JH.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):161-4. doi: 10.1097/WAD.0000000000000012.

How Preserved is Emotion Recognition in Alzheimer Disease Compared With Behavioral Variant Frontotemporal Dementia?

Bertoux M, de Souza LC, Sarazin M, Funkiewiez A, Dubois B, Hornberger M.

Alzheimer Dis Assoc Disord. 2015 Apr-Jun;29(2):154-7. doi: 10.1097/WAD.0000000000000023.

Quality of life in Alzheimer disease: a comparison of patients' and caregivers' points of view

Zucchella C, Bartolo M, Bernini S, Picascia M, Sinforiani E.

Alzheimer Dis Assoc Disord. 2015 Jan-Mar;29(1):50-4. doi: 10.1097/WAD.0000000000000050.

Donepezil improves gait performance in older adults with mild Alzheimer's disease: a phase II clinical trial

Montero-Odasso M, Muir-Hunter SW, Oteng-Amoako A, Gopaul K, Islam A, Borrie M, Wells J, Speechley M.

J Alzheimers Dis. 2015;43(1):193-9. doi: 10.3233/JAD-140759.

Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease

Kumar P, Jha NK, Jha SK, Ramani K, Ambasta RK.

J Alzheimers Dis. 2015;43(2):341-61. doi: 10.3233/JAD-140933.

Common mechanisms of Alzheimer's disease and ischemic stroke: the role of protein kinase C in the progression of age-related neurodegeneration

Lucke-Wold BP, Turner RC, Logsdon AF, Simpkins JW, Alkon DL, Smith KE, Chen YW, Tan Z, Huber JD, Rosen CL.

J Alzheimers Dis. 2015;43(3):711-24. doi: 10.3233/JAD-141422.

The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer's disease

Shoemark DK, Allen SJ.

J Alzheimers Dis. 2015;43(3):725-38. doi: 10.3233/JAD-141170.

Do patients with Alzheimer's disease draw like young children? An exploratory study

Bonoti F, Tzouvaleka E, Bonotis K, Vlachos F.

J Alzheimers Dis. 2015;43(4):1285-92. doi: 10.3233/JAD-140528.

The pathophysiology of axonal transport in Alzheimer's disease

Vicario-Orri E, Opazo CM, Muñoz FJ.

J Alzheimers Dis. 2015;43(4):1097-113. doi: 10.3233/JAD-141080.

The role of endocannabinoid signaling in the molecular mechanisms of neurodegeneration in Alzheimer's disease

Bedse G, Romano A, Lavecchia AM, Cassano T, Gaetani S.

J Alzheimers Dis. 2015;43(4):1115-36. doi: 10.3233/JAD-141635.

Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer's disease: a translational overview

Heckman PR, Wouters C, Prickaerts J.

Curr Pharm Des. 2015;21(3):317-31. doi: 10.2174/1381612820666140826114601.

Update on the neuroprotective effect of estrogen receptor alpha against Alzheimer's disease

Lan YL, Zhao J, Li S.

J Alzheimers Dis. 2015;43(4):1137-48. doi: 10.3233/JAD-141875.

Bacterial infection and Alzheimer's disease: a meta-analysis

Maheshwari P, Eslick GD.

J Alzheimers Dis. 2015;43(3):957-66. doi: 10.3233/JAD-140621.

Eye movements in Alzheimer's disease

Molitor RJ, Ko PC, Ally BA.

J Alzheimers Dis. 2015;44(1):1-12. doi: 10.3233/JAD-141173.

Potential therapeutic implications of gelsolin in Alzheimer's disease

Ji L, Zhao X, Hua Z.

J Alzheimers Dis. 2015;44(1):13-25. doi: 10.3233/JAD-141548.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias